Plasmodium Report

download Plasmodium Report

of 43

Transcript of Plasmodium Report

  • 7/29/2019 Plasmodium Report

    1/43

    PLASMODIUM

    Group 1

  • 7/29/2019 Plasmodium Report

    2/43

    Plasmodium

    The Plasmodiidae family has a single genus,

    Plasmodium, which includes those parasites

    that undergo exoerythrocytic and pigment-

    producing erythrocytic schizogony invertabrates and a sexual stage followed by

    sporogony in mosquitoes. (Faust, 1974)

  • 7/29/2019 Plasmodium Report

    3/43

    Plasmodium

    The sporozoan protozoa of the genus

    Plasmodium are pigment- producing ameboid

    intracellular parasites of vertebrates with one

    habitat in red cells and another in cells of othertissues. The definitive hosts are various

    species of mosquitoes of the genus

    Anopheles.

  • 7/29/2019 Plasmodium Report

    4/43

    Plasmodium

    The plasmodia normally infecting men are:

    Plasmodium vivax

    Plasmodium ovale

    Plasmodium malariae

    Plasmodium falciparum

  • 7/29/2019 Plasmodium Report

    5/43

    GENERAL LIFE CYCLE

    AND METHODS OFREPRODUCTION OF

    MALARIAL PARASITES OF

    MAN

  • 7/29/2019 Plasmodium Report

    6/43

    The malaria parasite exhibits a complex life

    cycle involving an insect vector (mosquito) and

    a vertebrate host (human). Four Plasmodium

    species infect humans: P. falciparum, P. vivax,P. ovaleand P. malariae. All four species

    exhibit a similar life cycle with only minor

    variations.

  • 7/29/2019 Plasmodium Report

    7/43

    The general life cycle of Plasmodia have two

    phases:

    (1) Extrinsic Phase inAnopheles: also called as

    Definitve phase in which sexual reproduction

    occurs

    (2) Intrinsic Phase in man: also called

    Intermediate phase in which asexual

    reproduction occurs.

  • 7/29/2019 Plasmodium Report

    8/43

    According to the CDC

    The malaria parasite is a multi-stage

    protozoan with a complex life cycle requiring

    an insect vector and a human host. There are

    three stages in its life cycle: the pre-erythrocitic cycle, the erythrocytic cycle,

    and the sporogonic cycle. (CDC)

  • 7/29/2019 Plasmodium Report

    9/43

  • 7/29/2019 Plasmodium Report

    10/43

    (video presentation)

  • 7/29/2019 Plasmodium Report

    11/43

    COMPARATIVECHARACTERS OF

    PLASMODIA OF MAN AND

    DISTINGUISHINGFEATURES

  • 7/29/2019 Plasmodium Report

    12/43

    P. vivax P. malariae P. falciparum P. ovaleEarly

    trophozoite

    or ring

    Relatively large;

    usually one

    prominent

    chromatin dot,sometimes two,

    often two rings or

    more in one cell

    Compact; one

    chromatin dot;

    double

    infection is rare

    Small, delicate;

    sometimes two

    chromatin dots;

    multiple redcell infection

    common;

    appliqu forms

    frequent

    Compact; one

    chromatin dot;

    double

    infectionuncommon

    Large

    trophozoite

    Large; markedly

    ameboid;abundant

    chromatin;

    prominent vacuole;

    pigment in fine

    rodlets

    Smaller than

    vivax; compact;often band

    shaped; not

    ameboid;

    vacuole

    inconspicuous;

    pigment iscoarse

    Medium size;

    usuallycompact, rarely

    ameboid;

    vacuole

    inconspicuous;

    rare in

    peripheralblood after half

    grown; pigment

    granular

    Small; compact;

    not ameboid;vacuole

    inconspicuous;

    pigment coarse

    Mature

    schizont or

    segmenter

    Large Small Small Medium

  • 7/29/2019 Plasmodium Report

    13/43

    P. vivax P. malariae P. falciparum P. ovaleNumber of

    merozites

    12-24 6-12 8-26 6-12

    Microgametocy

    tes and

    Macrogametoc

    ytes

    Spherical Spherical but

    smaller and less

    numerous

    Crescent

    shaped

    Spherical but

    smaller than

    vivax

    Alterations in

    infected red cell

    Enlarged and

    decolorized

    Cell may seem

    smaller; finestippling

    (Ziemanns

    dots)

    occasionally

    seen

    Normal size but

    may havebrassy

    appearance;

    Maurers dots

    common;

    Garnhams

    bodiesoccasionally

    seen.

    Enlarged;

    decolorized;prominent

    Schuffners

    dots, appear

    early; infected

    cells may be

    oval-shapedwith fimbriated

    ends

  • 7/29/2019 Plasmodium Report

    14/43

    P. vivax P. malariae P. falciparum P. ovaleLength of

    asexual phase

    48 hours 72 hours 36-48 hours 49-50 hours

    Parasitized

    red cells

    Enlarged.

    Fine stippling

    (Schuffners

    dots).

    Primarily

    invades

    reticulocytes,young red

    cells

    Not enlarged.

    No stippling

    (except with

    special stains)

    Primarily

    invades older

    red cells

    Not enlarged.

    Coarse

    stippling

    (Maurers

    clefts).

    Invades all red

    cellsregardless of

    age.

    Enlarged. Fine

    stippling. Cells

    often oval or

    fimbriated.

    Level of usual

    maximum

    parasitemia

    8 000- 20

    000/cu mm of

    blood

    < 10 000/cu

    mm

    1. 500

    000/cu

    mm

    < 10 000/cu

    mm

    Distribution All forms in

    peripheral

    blood.

    All forms in

    peripheral

    blood.

    Only rings and

    crescents

    (gametocytes)

    in peripheral

    blood

    All forms in

    peripheral

    blood.

  • 7/29/2019 Plasmodium Report

    15/43

    PATHOGENESIS

  • 7/29/2019 Plasmodium Report

    16/43

    Table of Pathogenesis

    (type diagram here)

  • 7/29/2019 Plasmodium Report

    17/43

    Mode of transmission

    Human infection results from the bite of an

    infected Anopheles Mosquito

  • 7/29/2019 Plasmodium Report

    18/43

    CLINICALMANIFESTATIONS

  • 7/29/2019 Plasmodium Report

    19/43

    There are no absolute diagnostic clinical

    features of malaria except fro the regular

    paroxysms of fever with asymptomatic

    intervals. Prodromal symptoms include: feeling of

    weakness and exhaustion, desire to stretch

    and yawn, aching bones, limbs and back,

    nausea, vomiting, and sense of chillness.

  • 7/29/2019 Plasmodium Report

    20/43

    The malaria paroxysms comprise three stages:

    cold stage

    the hot stage

    sweating stage.

  • 7/29/2019 Plasmodium Report

    21/43

    Cold Stage

    feeling of cold, apprehension, mild shivering

    quickly turns into violent teeth chattering and

    shaking of the whole body. The patient may

    vomit and febrile convulsions for youngchildren.Lasts for 15 to 60 min.

  • 7/29/2019 Plasmodium Report

    22/43

    Hot stage

    patients becomes hot and manifests with

    headache, palpitations, tachypnea, epigastric

    discomfort, thirst, nausea and vomiting. The

    temp ,ay reach up to 40 to 41 C. The patientmay become confused and delirious. The skin

    is flushed and hot. Lasts from 2 to 6 hours.

  • 7/29/2019 Plasmodium Report

    23/43

    Sweating Stage

    Defervescence or diaphoresis ensue with the

    patient manifesting with profuse sweating. The

    temperature lowers and symptoms diminish.

  • 7/29/2019 Plasmodium Report

    24/43

    Take Note!

    P.vivax, P. malariae, and P. ovale parasitimias islow grade , primarily because the parasites favoreither young or old RBC but not both.

    P. falciparum invades RBC of all ages andparasitemia is very high.

    P. falciparum also causes the parasitized red cellsto agglutinate and adhere to capillary walls , withresulting obstruction, thrombosis, and localischemia

    P. falciparum also causes severe or fatalcomplications such as cerebral malaria, malarialhyperpyrexia, gastrointestinal disorders and algid

    malaria

  • 7/29/2019 Plasmodium Report

    25/43

    Take Note!

    P. malariae has been implicated in a nephritic

    syndrome in childrenquartan nephrosis-

    with peak incidence at about age of 5. It is

    characterized by generalized edema, oliguria,massive proteinuria and hypoproteinemia.

    There are also presence glomerular lesions

    which include basement membrane thickening

    and sometimes fibrosis.

  • 7/29/2019 Plasmodium Report

    26/43

    DIAGNOSIS

  • 7/29/2019 Plasmodium Report

    27/43

    CLINICAL DIAGNOSIS

    Specimen: Blood

    Methods:

    thick- thin blood smear stained Romanowsky

    stainQuantitative buffy coat( QBC)

    ParaSightF test

    Indirect hemagglutination(IHA) Indirect luorescent antibody test( IFAT)

    ELISA

  • 7/29/2019 Plasmodium Report

    28/43

    THIN-FILMPREPARATIONS

  • 7/29/2019 Plasmodium Report

    29/43

    Plasmodium vivax

  • 7/29/2019 Plasmodium Report

    30/43

    Plasmodium ovale

  • 7/29/2019 Plasmodium Report

    31/43

    Plasmodium falciparum

  • 7/29/2019 Plasmodium Report

    32/43

    Plasmodium malariae

  • 7/29/2019 Plasmodium Report

    33/43

    THICK-FILMPREPARATIONS

  • 7/29/2019 Plasmodium Report

    34/43

    Plasmodium vivax

  • 7/29/2019 Plasmodium Report

    35/43

    Plasmodium falciparum

  • 7/29/2019 Plasmodium Report

    36/43

    Plasmodium malariae

  • 7/29/2019 Plasmodium Report

    37/43

    LABORATORYFINDINGS

  • 7/29/2019 Plasmodium Report

    38/43

    LABORATORY FINDINGS

    Normocytic anemia of variable severity, with

    poikilocytosis and anisocytosis

    During paroxysms there may be transient

    leukocytosis. Leukopenia develops with a relativeincrease in large mononuclear cells.

    Presence of casts and protein in the urine of

    children with P. malariae is suggestiveof quartan

    nephrosis. Severe P. falciparum infection , renal damage may

    cause oliguria and appearance of casts, protein,

    and RBSs.

  • 7/29/2019 Plasmodium Report

    39/43

    TREATMENT

  • 7/29/2019 Plasmodium Report

    40/43

    Treatment

    Chloroquine is the drug of choice

    Pyrimethamine/ sulfadoxine or quinine is used

    in areas where there is higher levels of

    resistance to chloroquinine

  • 7/29/2019 Plasmodium Report

    41/43

    PREVENTION ANDCONTROL

  • 7/29/2019 Plasmodium Report

    42/43

    Prevention and Control

    Elimination of mosquito breeding places or

    vector control

    Protection against mosquitoes such as

    screens, and mosquito repellants Suppressive drug therapy for exposed persons

    Use of flying insect spray containing pyrethrum

  • 7/29/2019 Plasmodium Report

    43/43

    THANK YOU